- Home
- BIYA vs CARM Comparison
BIYA vs CARM Comparison
Compare BIYA & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIYA
- CARM
- Stock Information
- Founded
- BIYA 2017
- CARM 2016
- Country
- BIYA China
- CARM United States
- Employees
- BIYA N/A
- CARM N/A
- Industry
- BIYA
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- BIYA
- CARM Health Care
- Exchange
- BIYA NYSE
- CARM Nasdaq
- Market Cap
- BIYA 7.8M
- CARM 8.4M
- IPO Year
- BIYA 2025
- CARM N/A
- Fundamental
- Price
- BIYA $0.75
- CARM $0.42
- Analyst Decision
- BIYA
- CARM Hold
- Analyst Count
- BIYA 0
- CARM 5
- Target Price
- BIYA N/A
- CARM $0.90
- AVG Volume (30 Days)
- BIYA 3.1M
- CARM 42.2M
- Earning Date
- BIYA 05-13-2025
- CARM 08-07-2025
- Dividend Yield
- BIYA N/A
- CARM N/A
- EPS Growth
- BIYA N/A
- CARM N/A
- EPS
- BIYA N/A
- CARM N/A
- Revenue
- BIYA $12,809,211.00
- CARM $19,964,000.00
- Revenue This Year
- BIYA N/A
- CARM N/A
- Revenue Next Year
- BIYA N/A
- CARM N/A
- P/E Ratio
- BIYA N/A
- CARM N/A
- Revenue Growth
- BIYA 10.66
- CARM 32.45
- 52 Week Low
- BIYA $0.59
- CARM $0.14
- 52 Week High
- BIYA $8.00
- CARM $1.66
- Technical
- Relative Strength Index (RSI)
- BIYA N/A
- CARM 52.94
- Support Level
- BIYA N/A
- CARM $0.37
- Resistance Level
- BIYA N/A
- CARM $0.44
- Average True Range (ATR)
- BIYA 0.00
- CARM 0.08
- MACD
- BIYA 0.00
- CARM -0.01
- Stochastic Oscillator
- BIYA 0.00
- CARM 15.55
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.